Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2647-2660
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2647
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2647
Table 1 List of the microRNAs involved in at least one of the main molecular pathways, and with a clinical significance, according to the present review
| miRNAs (regulation) | Pathway | Clinical |
| 99a | mTOR | Recurrence after resection |
| 497 | Recurrence after resection, recurrence after transplantation | |
| 195 | Recurrence after resection | |
| 140-5p | Recurrence after resection | |
| 23b | Recurrence after resection | |
| 223 | Recurrence after resection | |
| 199a-5p | Recurrence after transplantation | |
| 181a-5p | Resistance to Sorafenib/CHT | |
| 33a-5p | Resistance to Sorafenib/CHT | |
| 125b | Wnt | Recurrence after resection, recurrence after transplantation |
| 195 | Recurrence after resection | |
| 18 (up) | Recurrence after transplantation | |
| 140-5p | JAK-STAT | Recurrence after resection |
| 365 | Apoptosis | Recurrence after resection |
| 125a | MAPK | Recurrence after resection, resistance to Sorafenib/CHT |
- Citation: Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D’Errico A, de Biase D. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2647-2660
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2647.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2647